Alimera sciences pre-announces expected top line revenue for q1 2020

Alimera sciences pre-announces expected top line revenue for q1 2020 and provides covid-19 business update.alimera sciences inc - expects to report consolidated net revenue for q1 of 2020 exceeding $14 million.alimera sciences inc - expects to report cash on hand in excess of $12 million at march 31.alimera sciences inc - withdrawing any previously communicated guidance regarding revenue growth and cash flow in 2020.alimera sciences inc - have no plans at this time to make any staffing level changes.alimera sciences inc - believes it currently has sufficient inventory in its supply chain to meet demand.alimera sciences inc - continues to work with its third-party manufacturers regarding continued production of iluvien.
ALIM Ratings Summary
ALIM Quant Ranking